Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited
about
Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune TargetsAdoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advancesCAR T Cell Therapy: A Game Changer in Cancer TreatmentEvaluation of current cancer immunotherapy: hemato-oncologyDonor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose.Irradiation of peripheral blood mononuclear cells with 7.5 Gy X-rays prior to donor lymphocyte infusion inhibits proliferation while preserving cytotoxicity, and improves the effectiveness of HSCT in patients with hematological malignancies.Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.Visualization of immune response kinetics in full allogeneic chimeras.Effects of intrabone marrow-bone marrow transplantation plus adult thymus transplantation on survival of mice bearing leukemiaPretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcomeTolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia.Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study.Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia.Targeting T cells with bispecific antibodies for cancer therapyDonor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplAnalysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors.Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.The role of allogeneic haematopoietic progenitor cell transplantation in patients with diffuse large B-cell non-Hodgkin lymphomas (DLBCL).CAR T cells: driving the road from the laboratory to the clinic.Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.Adoptive T-cell therapy: a need for standard immune monitoring.New strategies of DLI in the management of relapse of hematological malignancies after allogeneic hematopoietic SCT.Hematopoietic stem cell transplantation in advanced cutaneous T-cell lymphoma.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature.Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response.Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients.A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent.CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia.The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.Efficacy of intracellular immune checkpoint-silenced DC vaccine.Tissue-based chimerism analysis enhances detection of donor-derived neoplasia in allogeneic stem cell transplant patients.
P2860
Q26750999-123778B6-D2B4-4AE4-928F-93C88EE4FD96Q26775720-E23CA16A-8219-4787-B9EE-578D16BB9858Q26822769-951A3489-6168-471C-BF8B-C0A8FFE254FAQ27006179-D6A74ED4-4B3C-4780-AE42-EB473D07E4BFQ30558271-01C9DBCC-2B17-4973-985C-908B3D5BF199Q33750829-3A36F5A0-895B-4020-83B4-867FF869F3A9Q33937048-B7AF59CB-8CB3-41F5-B05D-F0026ADB4D8FQ35824974-1B711916-FEEB-44D1-8087-4F228038191EQ35986232-00CC6050-B86D-4234-88D7-957F14EA3F5DQ36059184-2A90284C-14C5-4F44-B3BF-313D2ABBE5DAQ36110355-7CD4B1C5-FC21-4C9E-B938-6E98B842B6B3Q36255385-08D38DD9-1751-4B01-B93E-CAC2E0950EB4Q37148120-A2FC2C81-FEA2-4BCB-B570-9690F608AA55Q37220742-32419A44-0EB8-44D8-81FA-2F6669E6A680Q37390239-B6AE6BCC-94CD-412F-A8B6-6E994F179B37Q37609957-BD88850D-2D77-4C67-BAC0-33155890D031Q37697105-272E84BD-72E7-4605-8F49-6A02F2B45BC9Q37727668-5155BB80-131D-46C4-8C52-F0D4BF6272DFQ37905034-1447B120-D14F-435F-81C9-3A30E98E03B3Q38074021-B77A7134-1E83-46A6-9CEF-E540B6FF11DAQ38170499-3251319B-E523-4A1A-A568-BBE3E34C77D4Q38219579-D3246288-1F71-46AB-9330-1595C0FCC591Q38525029-7D8446FD-79B5-4DEC-8934-21359A431F78Q38643400-D8C7F53A-2C4D-40F4-B547-6832124C69C5Q38845879-0F3A5522-16DC-484C-B086-9EED25C51126Q38897538-0EE8BA13-5E99-493E-B094-094C73EA9FE8Q41336256-00E6571B-1195-4A1B-9F8F-5D22CD9BCB74Q41757334-4BA66991-C2E2-48D1-9D1D-02B8892DF461Q42084183-AE40F10B-6A7F-4E0D-B337-C86825385EA5Q44208467-5A9177E0-7324-4E42-ADFF-82DB0394956AQ45077774-8412712B-7DBB-4CDC-ADA3-F91767FFD751Q46018826-26042C5E-1827-4698-AECB-B74F472D2619Q49307766-DF12F582-CF31-4CF9-89D1-90D69E5FBAF5Q50130525-FE0882FF-698D-40A5-87E0-47B92E243E3DQ52812076-71CF8D97-3E1C-436D-A7A2-8FE0EC9CE633
P2860
Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of donor lymphocyte infus ...... cell transplantation revisited
@ast
Role of donor lymphocyte infus ...... cell transplantation revisited
@en
Role of donor lymphocyte infus ...... cell transplantation revisited
@nl
type
label
Role of donor lymphocyte infus ...... cell transplantation revisited
@ast
Role of donor lymphocyte infus ...... cell transplantation revisited
@en
Role of donor lymphocyte infus ...... cell transplantation revisited
@nl
prefLabel
Role of donor lymphocyte infus ...... cell transplantation revisited
@ast
Role of donor lymphocyte infus ...... cell transplantation revisited
@en
Role of donor lymphocyte infus ...... cell transplantation revisited
@nl
P2860
P1476
Role of donor lymphocyte infus ...... cell transplantation revisited
@en
P2093
Abhinav Deol
Lawrence G Lum
P2860
P304
P356
10.1016/J.CTRV.2010.03.004
P577
2010-04-09T00:00:00Z